This phenotype of Lcn2 depletion-mediated acute pancreatitis could be prevented by treatment with the ferroptosis inhibitor liproxstatin-1 or the iron chelator DFO (Fig. 6b–h). This evidence concerns the gene LCN2 and acute pancreatitis.